QR kód

Chemotherapy receipt in affected BRCA1/2 and PALB2 carriers with operable breast cancer: the impact of early detection and pre-diagnostic awareness on clinical outcomes and treatment

Abstract Purpose While enhanced breast screening of germline pathogenic variant (GPV) carriers results in earlier stage at diagnosis, the impact of tumour biology and GPV on chemotherapy receipt in early-stage disease remains understudied. Methods We retrospectively reviewed treatment administered f...

Celý popis

Uloženo v:
Hlavní autoři: Stephanie M. Wong, Carla Apostolova, Amina Ferroum, Basmah Alhassan, Ipshita Prakash, Mark Basik, Karyne Martel, Sarkis Meterissian, David Fleiszer, Nora Wong, Michaela Bercovitch Sadinsky, Talia Malagon, Jean Francois Boileau, William D. Foulkes
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2025-04-01
Edice:Hereditary Cancer in Clinical Practice
Témata:
Breast neoplasms
BRCA1/2
Hereditary breast cancer
Chemotherapy
On-line přístup:https://doi.org/10.1186/s13053-025-00314-x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky